What question did this study set out to answer?

To evaluate whether a targeted proteomic risk model improves the prediction of recurrent cardiovascular events compared to traditional clinical risk scoring in secondary prevention.

January 28, 2022European Heart JournalOpen Access

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

View Full Paper

Ask AI

Bookmark

To evaluate whether a targeted proteomic risk model improves the prediction of recurrent cardiovascular events compared to traditional clinical risk scoring in secondary prevention.
Constructed a targeted proteome-based risk prediction model and compared its prognostic utility against a standard clinical risk model for recurrent atherosclerotic cardiovascular disease events.
Analyzed biological pathways in patient subsets, focusing on residual inflammatory mechanisms in individuals with low C-reactive protein levels.
Quantified model performance and clinical utility using net reclassification improvement metrics.
The proteome-based risk model demonstrated superior predictive capability over clinical risk models for recurrent atherosclerotic cardiovascular disease events.
Neutrophil-related pathways were active in patients with low C-reactive protein, indicating significant residual inflammatory risk independent of standard NLRP3 pathways.
Targeted proteomics yielded a positive net reclassification improvement, supporting its utility for tailoring secondary prevention therapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Risk modeling demonstrates superior prediction of recurrent cardiovascular events in secondary prevention patients, suggesting residual inflammatory pathways beyond standard markers.

Cite This Study

Nurmohamed et al. (2022) studied this question.

synapsesocial.com/papers/69dd28e827c48be1bb40c3a5 https://doi.org/10.1093/eurheartj/ehac055

View Full Paper

Ask AI

Bookmark

Implication

Risk modeling demonstrates superior prediction of recurrent cardiovascular events in secondary prevention patients, suggesting residual inflammatory pathways beyond standard markers.

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

Key Points

Discussion

Implication

Cite This Study

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider